Ranitidine Tablet
Product Images NDC 53746-253

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 53746-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Click To Zoom In (Ranitidine Tablets Usp 1)

FDA Label Image

100 Ct. (Ranitidine Tablets Usp 2)

100 Ct. (Ranitidine Tablets Usp 2)
NDC 53746-253-01 is a medication called Ranitidine in the form of tablets. Each tablet contains 150 mg of ranitidine as ranitidine hydrochloride. The package insert should be referred to for dosage and administration instructions. The tablets should be stored in a dry place at 20°C to 25°C (68°F to 77°F), in a light-resistant container as defined in the USP. They should be protected from light, and the cap should be replaced securely after each opening. The medication is distributed by Amneal Pharmaceuticals in Bridgewater, NJ.*
FDA Label Image

100 Ct. (Ranitidine Tablets Usp 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.